Anbio Biotechnology Realized Investment Gains (Losses)
Anbio Biotechnology (NNNN) reported Realized Investment Gains (Losses) of -$68.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-04-07
| Period end | Realized Investment Gains (Losses) 12 month |
|---|---|
| 2025-12-31 | -$68.00K 20-F · filed 2026-04-07 |
| 2024-12-31 | $337.10K 20-F · filed 2026-04-07 |
| 2023-12-31 | $163.39K 20-F · filed 2026-04-07 |
| 2022-12-31 | $38.88K 20-F · filed 2025-04-28 |